|
|
|
|
|
by ethbr0
2110 days ago
|
|
His point was more along the lines of it being poorly designed. Evolution isn't going to nicely separate functionality into clean, single-purpose biochemical pathways. It's going to overload something that it already has to support a new feature, leading to a rat's nest of intertwined effects. The hard part in drug development isn't affecting your target: that's pretty easy to guarantee with modern tools. It's finding out that that target also governs 10 other, completely unrelated bodily functions. |
|
Some companies in the valley just call that Wednesday.=)